Correlation Between ASTELLAS PHARMA and Astellas Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ASTELLAS PHARMA and Astellas Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ASTELLAS PHARMA and Astellas Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ASTELLAS PHARMA UNSPADR and Astellas Pharma, you can compare the effects of market volatilities on ASTELLAS PHARMA and Astellas Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ASTELLAS PHARMA with a short position of Astellas Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ASTELLAS PHARMA and Astellas Pharma.

Diversification Opportunities for ASTELLAS PHARMA and Astellas Pharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between ASTELLAS and Astellas is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ASTELLAS PHARMA UNSPADR and Astellas Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Astellas Pharma and ASTELLAS PHARMA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ASTELLAS PHARMA UNSPADR are associated (or correlated) with Astellas Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Astellas Pharma has no effect on the direction of ASTELLAS PHARMA i.e., ASTELLAS PHARMA and Astellas Pharma go up and down completely randomly.

Pair Corralation between ASTELLAS PHARMA and Astellas Pharma

If you would invest (100.00) in ASTELLAS PHARMA UNSPADR on September 1, 2024 and sell it today you would earn a total of  100.00  from holding ASTELLAS PHARMA UNSPADR or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

ASTELLAS PHARMA UNSPADR  vs.  Astellas Pharma

 Performance 
       Timeline  
ASTELLAS PHARMA UNSPADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ASTELLAS PHARMA UNSPADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, ASTELLAS PHARMA is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Astellas Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Astellas Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

ASTELLAS PHARMA and Astellas Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ASTELLAS PHARMA and Astellas Pharma

The main advantage of trading using opposite ASTELLAS PHARMA and Astellas Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ASTELLAS PHARMA position performs unexpectedly, Astellas Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Astellas Pharma will offset losses from the drop in Astellas Pharma's long position.
The idea behind ASTELLAS PHARMA UNSPADR and Astellas Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios